Latest TIMI Stories
SAN DIEGO, May 15, 2015 /PRNewswire/ -- Angionetics Inc., a majority-owned operating unit of Taxus Cardium Pharmaceuticals Group (Symbol: CRXM), today announced a presentation at the 18(th)
The inaugural TechInsurance Market Index (TIMI) provides a snapshot of small IT business needs and risks. CHICAGO, Oct.
Pioneering Angiogenic Gene Therapy for the Potential Treatment of Millions of Patients with Heart Disease Worldwide SAN DIEGO, June 24, 2014 /PRNewswire/ -- Taxus Cardium Pharmaceuticals
'Hubs' offer personal health consultations, blood draws and group classes in a modern, stylish environment RICHMOND, Va., April 1, 2014 /PRNewswire/ -- Health Diagnostic Laboratory,
Patient Recruitment and Enrollment Now Underway WOODCLIFF LAKE, N.J., Feb. 24, 2014 /PRNewswire/ -- Eisai Inc.
In an analysis of blood pressure patterns over a 25-year span from young adulthood to middle age, individuals who exhibited elevated and increasing blood pressure levels throughout this time period had greater odds of having higher measures of coronary artery calcification (a measure of coronary artery atherosclerosis).
While a new class of diabetes pill known as DPP-4 inhibitors does not appear to increase a person’s risk of heart attack, there is some indication that there could be other negative cardiovascular effects associated with the drugs.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.